Immediate Impact
74 standout
Citing Papers
Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study
2024 Standout
Chemistry, structure and function of approved oligonucleotide therapeutics
2023 Standout
Works of C PULIAFITO being referenced
Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular DegenerationTwelve-Week Results of an Uncontrolled Open-Label Clinical Study
2005 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| C PULIAFITO | 681 | 547 | 108 | 150 | 3 | 750 | |
| M.F. Escaño | 665 | 504 | 117 | 109 | 11 | 744 | |
| Steven Agemy | 669 | 585 | 103 | 50 | 12 | 735 | |
| Hoseong S. Yang | 552 | 276 | 16 | 478 | 6 | 802 | |
| SE Moss | 693 | 546 | 23 | 198 | 4 | 921 | |
| David Fei | 478 | 423 | 18 | 331 | 7 | 807 | |
| James Warburton | 845 | 641 | 18 | 149 | 5 | 907 | |
| Adam T. Chin | 810 | 762 | 119 | 137 | 14 | 957 | |
| DANIELLE L.L. COSTA | 885 | 401 | 38 | 97 | 11 | 907 | |
| Ahmed Z. Soliman | 561 | 532 | 20 | 49 | 9 | 651 | |
| Maria Swift | 677 | 560 | 21 | 151 | 4 | 730 |
All Works
Loading papers...